Literature DB >> 9279150

Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction.

D A Clark1, I M Kidd, K E Collingham, M Tarlow, T Ayeni, A Riordan, P D Griffiths, V C Emery, D Pillay.   

Abstract

Primary human herpesvirus 6 (HHV-6) and 7 (HHV-7) infections were identified in febrile children by qualitative and quantitative polymerase chain reaction (PCR) assays. Diagnosis was based on the differential detection of viral DNA in peripheral blood mononuclear cells (PBMC), but not in saliva. Six of 41 febrile infants, but none of seven non-febrile controls, were identified with primary infections (three HHV-6, three HHV-7). These children had significantly higher viral loads in PBMC (HHV-6, median 24213 genomes/10(6) PBMC; HHV-7, median 6,040,000 genomes/10(6) PBMC) than DNA-aemic, saliva PCR positive children (HHV-6, median 1606 genomes/10(6) PBMC, p < 0.01; HHV-7, median 7089 genomes/ 10(6) PBMC, p < 0.05). Viral DNA was detected in serum by PCR in only 50% of primary infections. All three children with primary HHV-7 infection had febrile convulsions. Thus PCR, including quantitative assays, may identify primary HHV-6 and HHV-7 infections when an appropriate combination of clinical specimens is used.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279150      PMCID: PMC1717251          DOI: 10.1136/adc.77.1.42

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction.

Authors:  I M Kidd; D A Clark; M Ait-Khaled; P D Griffiths; V C Emery
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

2.  Prevalence of antibody to human herpesvirus 7 by age.

Authors:  D A Clark; M L Freeland; L K Mackie; R F Jarrett; D E Onions
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

3.  Human herpesvirus 7 infection associated with central nervous system manifestations.

Authors:  S Torigoe; W Koide; M Yamada; E Miyashiro; K Tanaka-Taya; K Yamanishi
Journal:  J Pediatr       Date:  1996-08       Impact factor: 4.406

4.  Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction.

Authors:  K Tanaka-Taya; T Kondo; T Mukai; H Miyoshi; Y Yamamoto; S Okada; K Yamanishi
Journal:  J Med Virol       Date:  1996-01       Impact factor: 2.327

5.  Human herpesvirus 7: antigenic properties and prevalence in children and adults.

Authors:  L S Wyatt; W J Rodriguez; N Balachandran; N Frenkel
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction.

Authors:  A J Wakefield; J D Fox; A M Sawyerr; J E Taylor; C H Sweenie; M Smith; V C Emery; M Hudson; R S Tedder; R E Pounder
Journal:  J Med Virol       Date:  1992-11       Impact factor: 2.327

7.  Primary human herpesvirus-6 infection is frequently overlooked as a cause of febrile fits in young children.

Authors:  K N Ward; J J Gray
Journal:  J Med Virol       Date:  1994-02       Impact factor: 2.327

8.  Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma.

Authors:  L M Huang; P F Kuo; C Y Lee; J Y Chen; M Y Liu; C S Yang
Journal:  J Med Virol       Date:  1992-09       Impact factor: 2.327

9.  Human herpesvirus 7: another causal agent for roseola (exanthem subitum).

Authors:  K Tanaka; T Kondo; S Torigoe; S Okada; T Mukai; K Yamanishi
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

10.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

View more
  8 in total

1.  Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patients.

Authors:  G Fabio; S N Knight; I M Kidd; S M Noibi; M A Johnson; V C Emery; P D Griffiths; D A Clark
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections.

Authors:  K N Ward; D J Turner; X C Parada; A D Thiruchelvam
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  An immunoblot assay for detection of immunoglobulin M antibody to human herpesvirus 6.

Authors:  S LaCroix; J A Stewart; M E Thouless; J B Black
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

4.  Detection of human herpesvirus 6 by reverse transcription-PCR.

Authors:  R A Norton; M T Caserta; C B Hall; K Schnabel; P Hocknell; S Dewhurst
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7.

Authors:  F M Mattes; J E McLaughlin; V C Emery; D A Clark; P D Griffiths
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

6.  Real-time quantitative PCR for human herpesvirus 6 DNA.

Authors:  G Locatelli; F Santoro; F Veglia; A Gobbi; P Lusso; M S Malnati
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 7.  Human herpesvirus 6 (HHV6) infection.

Authors:  Nahed M Abdel-Haq; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 5.319

8.  Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study.

Authors:  Luca Bartolini; Eleonora Piras; Kathryn Sullivan; Sean Gillen; Adrian Bumbut; Cheng-Te Major Lin; Emily C Leibovitch; Jennifer S Graves; Emmanuelle L Waubant; James M Chamberlain; William D Gaillard; Steven Jacobson
Journal:  Front Neurol       Date:  2018-10-05       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.